Agency Forms Undergoing Paperwork Reduction Act Review, 59427-59429 [2022-21218]
Download as PDF
<![CDATA[
59427
Federal Register / Vol. 87, No. 189 / Friday, September 30, 2022 / Notices
empirical evidence regarding
remuneration and coercion. Procedures
for each of these studies will be similar
to those applied in the usual testing of
survey questions. For example,
questionnaires that are of current
interest (such as RANDS and NIOSH)
may be evaluated using several of the
techniques described above, or different
versions of a survey question will be
Types of
respondents
Individuals
Individuals
Individuals
Individuals
Individuals
or
or
or
or
or
households
households
households
households
households
Estimated Annualized Burden Table
Number of
responses per
respondent
Number of
respondents
Form name
Average
hours per
response
(in hours)
Total
burden
hours
.................
.................
.................
.................
.................
Eligibility Screeners ..........................
Developmental Questionnaires ........
Respondent Data Collection Sheet ..
Focus Group Documents .................
RANDS Methodological Surveys .....
4,400
8,750
8,750
225
49,800
1
1
1
1
1
5/60
55/60
5/60
1.5
15/60
367
8,021
729
338
12,450
Total ...........................................
...........................................................
........................
........................
........................
21,905
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–21221 Filed 9–29–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–0234]
Agency Forms Undergoing Paperwork
Reduction Act Review
jspears on DSK121TN23PROD with NOTICES
to our specific questionnaire
development activities in order to
improve the methods that we use to
conduct questionnaire testing, and to
guide questionnaire design in general.
CDC requests OMB approval for an
estimated 21,905 annualized burden
hours. There is no cost to respondents
other than their time to participate.
developed, and the variants then
administered to separate groups of
respondents in order to study the
cognitive processes that account for the
differences in responses obtained across
different versions.
These studies will be conducted
either by CCQDER staff, DHHS staff, or
NCHS contractors who are trained in
cognitive interviewing techniques. The
results of these studies will be applied
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘The National
Ambulatory Medical Care Survey
(NAMCS)’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on March 18,
2022, to obtain comments from the
public and affected agencies. One nonsubstantive public comment was
received related to the previous notice.
This notice serves to allow an additional
30 days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
VerDate Sep<11>2014
18:52 Sep 29, 2022
Jkt 256001
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Proposed Project
National Ambulatory Medical Care
Survey (NAMCS) (OMB Control No.
0920–0234, Exp. 07/31/2024)—
Revision—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Ambulatory Medical
Care Survey (NAMCS) was conducted
intermittently from 1973 through 1985,
and annually since 1989. The survey is
conducted under authority of Section
306 of the Public Health Service Act (42
U.S.C. 242k). NAMCS is part of the
ambulatory care component of the
National Health Care Surveys (NHCS), a
family of provider-based surveys that
capture health care utilization from a
variety of settings, including hospital
inpatient and long-term care facilities.
NCHS surveys of health care providers
include NAMCS, the National Hospital
Ambulatory Medical Care Survey
(NHAMCS) (OMB Control No. 0920–
0278), the National Hospital Care
Survey (OMB Control No. 0920–0212),
and the National Post-acute and Longterm Care Study (OMB Control No.
0920–0943).
An overarching purpose of NAMCS is
to meet the needs and demands for
statistical information about the
provision of ambulatory medical care
services in the United States; this fulfills
one of NCHS missions, to collect,
analyze, and disseminate timely,
relevant, and accurate health data and
statistics. In addition, NAMCS provides
ambulatory medical care data to study:
(1) the performance of the U.S. health
care system; (2) care for the rapidly
aging population; (3) changes in services
E:\FR\FM\30SEN1.SGM
30SEN1
59428
Federal Register / Vol. 87, No. 189 / Friday, September 30, 2022 / Notices
such as health insurance coverage
change; (4) the introduction of new
medical technologies; and (5) the use of
electronic health records (EHRs).
Ongoing societal changes have led to
considerable diversification in the
organization, financing, and
technological delivery of ambulatory
medical care. This diversification is
evidenced by the proliferation of
insurance and benefit alternatives for
individuals, the development of new
forms of physician group practices and
practice arrangements (such as officebased practices owned by hospitals), the
increasing role of advanced practice
providers delivering clinical care, and
growth in the number of alternative sites
of care. Ambulatory services are
rendered in a wide variety of settings,
including physician/provider offices
and hospital outpatient and emergency
departments. Since more than 65% of
ambulatory medical care visits occur in
physician offices, NAMCS provides data
on the majority of ambulatory medical
care services.
In addition to health care provided in
physician offices and outpatient and
emergency departments, health centers
(HCs) play an important role in the
health care community by providing
care to people who might not be able to
afford it otherwise. HCs are local, nonprofit, community-owned health care
settings, which serve approximately 29
million individuals throughout the
United States. NAMCS collects and
provides data on HCs via the NAMCS
HC Component. In addition to the HC
component NAMCS includes a Provider
Interview Component and a Provider
Electronic Component. The Provider
Interview Component samples
ambulatory care providers to collect
information on their characteristics and
the characteristics of their practice. The
Provider Electronic Component gathers
information on a sample of electronic
data providers including characteristics
of the provider, as well as a full year of
electronic patient visit data. Lastly, the
HC Component samples HCs and
collects characteristics of the center as
well as a full year of electronic patient
visit data.
This revision seeks approval to
continue previously approved survey
activities for the completion of the 2022
HC Component’s data and to conduct
the full 2023, 2024, and 2025 data years.
CDC plans to implement changes to all
three components of NAMCS. HC
Component and Provider Interview
Component sample sizes will be
adjusted. In 2022, the goal is to target
100 HCs overall, while the Provider
Interview Component is paused for
redesign. In 2023, the goal for NAMCS
is to sample 5,000 physicians, 5,000
advanced practice providers, and up to
150 HCs overall. In 2024, we plan to
sample up to 10,000 physicians, 20,000
advanced practice providers, and up to
200 HCs overall (if funds allow). Lastly,
in 2025 CDC will sample up to 20,000
physicians, 40,000 advanced practice
providers, and up to 250 HCs overall.
For 2023–2025, there will be an
additional 3,000 physicians sampled
yearly for the Provider Electronic
Component. The Provider Electronic
Component is modifying its Provider
Facility Interview questionnaire and
there are plans to implement a set-up
fee in the future. Also, for the Provider
Electronic Component we plan to
conduct research on supplementing
electronic visit data with electronic data
obtained from third-party sources.
Questions on the Health Center Facility
Interview questionnaire will be
modified, and a Set-up Fee
Questionnaire will be implemented. In
2023, the Physician Induction Interview
will shift to a redesigned Ambulatory
Care Provider Interview. Also beginning
in 2023, a Tracing Questionnaire will be
utilized for the Provider Interview
Component, to increase response rates.
Visit data collection via abstraction will
be placed on hold to evaluate improved
methods for collection of these data, and
the reinterview study will be
discontinued. The provider incentive
experiment will also no longer be taking
place, as we will begin to conduct other
methodological work to improve upon
the survey.
CDC requests OMB approval for an
estimated 37,744 burden hours. There
are no costs to respondents other than
their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
HC Staff ..........................................................
HC Facility Interview questionnaire (Survey
year: 2022).
Prepare and transmit EHR for Visit Data
(quarterly) (Survey year: 2022).
Set-up Fee Questionnaire (Survey year:
2022).
ACPI (Survey year: 2023–2025) ....................
Contact Tracing (Survey year: 2023–2025) ...
ACPI (Survey year: 2023–2025) ....................
Contact Tracing (Survey year: 2023–2025) ...
PFI Survey year: 2023–2025) ........................
Prepare and transmit Electronic Visit Data
(quarterly) (Survey year: 2023–2025).
HC Facility Interview questionnaire (Survey
year: 2023–2025).
Prepare and transmit EHR for Visit Data
(quarterly) (Survey year: 2023–2025).
Set-up Fee Questionnaire (Survey year:
2023–2025).
Physician or Staff ............................................
Advanced Practice Provider or Staff ..............
Ambulatory Care Provider or Group or Conglomerate Staff.
HC Staff ..........................................................
jspears on DSK121TN23PROD with NOTICES
Number of
respondents
Type of respondents
VerDate Sep<11>2014
18:52 Sep 29, 2022
Jkt 256001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
73
1
45/60
33
4
60/60
33
1
15/60
11,667
11,667
21,667
21,667
3,000
3,000
1
1
1
1
1
4
30/60
10/60
30/60
10/60
45/60
60/60
300
1
45/60
200
4
60/60
200
1
15/60
E:\FR\FM\30SEN1.SGM
30SEN1
Federal Register / Vol. 87, No. 189 / Friday, September 30, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–21218 Filed 9–29–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1150]
jspears on DSK121TN23PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Generic
Clearance for Lyme and other Tickborne
Diseases Knowledge, Attitudes, and
Practices Surveys’’ to the Office of
Management and budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on March 18,
2022 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
VerDate Sep<11>2014
18:52 Sep 29, 2022
Jkt 256001
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Lyme and other Tickborne Diseases
Knowledge, Attitudes, and Practices
Surveys (OMB Control Number 0920–
1150, Exp. 9/30/2022)—Revision—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) Division of VectorBorne Diseases (DVBD) and other
programs working on tickborne diseases
(TBDs) are requesting a Revision to a
previously approved generic clearance
to conduct TBD prevention studies to
include knowledge, attitudes, and
practices (KAP) surveys regarding ticks
and tickborne diseases (TBDs) among
residents and businesses offering pest
control services in Lyme disease
endemic areas of the United States. The
data collection for which approval is
sought will allow DVBD to use survey
results to inform implementation of
future TBD prevention interventions.
The Revision involves a broadening of
the secondary target population from
owners and employees of pest control
companies to stakeholders of local
entities affected by TBDs (e.g., leaders in
local public health or local government;
owners or employees of pest control
companies, landscaping companies, or
other at-risk occupations; nongovernmental organizations serving atrisk populations; and/or clinicians
serving at-risk populations).
TBDs are a substantial and growing
public health problem in the United
States. From 2004–2016, over 490,000
cases of TBDs were reported to CDC,
including cases of anaplasmosis,
babesiosis, ehrlichiosis, Lyme disease,
Rocky Mountain spotted fever, and
tularemia. Lyme disease accounted for
82% of all TBDs, with over 400,000
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
59429
cases reported during this time period.
Recent studies estimate nearly 500,000
cases of Lyme disease are diagnosed
annually in the United States. In
addition, several novel tickborne
pathogens have recently been found to
cause human disease in the United
States. Factors driving the emergence of
TBDs are not well defined and current
prevention methods have been
insufficient to curb the increase in
cases. Data is lacking on how often
certain prevention measures are used by
individuals at risk, as well as what the
barriers to using certain prevention
measure are.
The primary target population for
these data collections are individuals
and their household members who are
at risk for TBDs associated with
I.scapularis ticks and who may be
exposed to these ticks residentially,
recreationally, and/or occupationally.
The secondary target population
includes stakeholders of local entities
affected by TBDs (e.g., leaders in local
public health or local government;
owners or employees of pest control
companies, landscaping companies, or
other at-risk occupations; nongovernmental organizations serving atrisk populations; and/or clinicians
serving at-risk populations) in areas
where I. scapularis ticks transmit
diseases to humans. Specifically, these
target populations include those
residing or working in the 15 highest
incidence states for Lyme disease (CT,
DE, ME, MD, MA, MN, NH, NJ, NY, PA,
RI, VT, VA, WI and WV). We anticipate
conducting one to two surveys per year,
for a maximum of six surveys conducted
over a three-year period. Depending on
the survey, we aim to enroll 500–10,000
participants per study. It is expected
that we will need to target recruitment
to about twice as many people as we
intend to enroll. Surveys may be
conducted daily, weekly, monthly, or
bi-monthly per participant for a defined
period (whether by phone or web
survey), depending on the survey or
study. The surveys will range in
duration from approximately 5–30
minutes. Each participant may be
surveyed 1–64 times in one year; this
variance is due to differences in the type
of information collected for a given
survey. Specific burden estimates for
each study and each information
collection instrument will be provided
with each individual project submitted
for OMB review. Insights gained from
KAP surveys will aid in prioritizing
which prevention methods should be
evaluated in future randomized,
controlled trials and ultimately help
target promotion of proven prevention
E:\FR\FM\30SEN1.SGM
30SEN1
]]>Agencies
[Federal Register Volume 87, Number 189 (Friday, September 30, 2022)]
[Notices]
[Pages 59427-59429]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21218]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0234]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``The National Ambulatory Medical Care Survey
(NAMCS)'' to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on March 18,
2022, to obtain comments from the public and affected agencies. One
non-substantive public comment was received related to the previous
notice. This notice serves to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Ambulatory Medical Care Survey (NAMCS) (OMB Control No.
0920-0234, Exp. 07/31/2024)--Revision--National Center for Health
Statistics (NCHS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The National Ambulatory Medical Care Survey (NAMCS) was conducted
intermittently from 1973 through 1985, and annually since 1989. The
survey is conducted under authority of Section 306 of the Public Health
Service Act (42 U.S.C. 242k). NAMCS is part of the ambulatory care
component of the National Health Care Surveys (NHCS), a family of
provider-based surveys that capture health care utilization from a
variety of settings, including hospital inpatient and long-term care
facilities. NCHS surveys of health care providers include NAMCS, the
National Hospital Ambulatory Medical Care Survey (NHAMCS) (OMB Control
No. 0920-0278), the National Hospital Care Survey (OMB Control No.
0920-0212), and the National Post-acute and Long-term Care Study (OMB
Control No. 0920-0943).
An overarching purpose of NAMCS is to meet the needs and demands
for statistical information about the provision of ambulatory medical
care services in the United States; this fulfills one of NCHS missions,
to collect, analyze, and disseminate timely, relevant, and accurate
health data and statistics. In addition, NAMCS provides ambulatory
medical care data to study: (1) the performance of the U.S. health care
system; (2) care for the rapidly aging population; (3) changes in
services
[[Page 59428]]
such as health insurance coverage change; (4) the introduction of new
medical technologies; and (5) the use of electronic health records
(EHRs). Ongoing societal changes have led to considerable
diversification in the organization, financing, and technological
delivery of ambulatory medical care. This diversification is evidenced
by the proliferation of insurance and benefit alternatives for
individuals, the development of new forms of physician group practices
and practice arrangements (such as office-based practices owned by
hospitals), the increasing role of advanced practice providers
delivering clinical care, and growth in the number of alternative sites
of care. Ambulatory services are rendered in a wide variety of
settings, including physician/provider offices and hospital outpatient
and emergency departments. Since more than 65% of ambulatory medical
care visits occur in physician offices, NAMCS provides data on the
majority of ambulatory medical care services.
In addition to health care provided in physician offices and
outpatient and emergency departments, health centers (HCs) play an
important role in the health care community by providing care to people
who might not be able to afford it otherwise. HCs are local, non-
profit, community-owned health care settings, which serve approximately
29 million individuals throughout the United States. NAMCS collects and
provides data on HCs via the NAMCS HC Component. In addition to the HC
component NAMCS includes a Provider Interview Component and a Provider
Electronic Component. The Provider Interview Component samples
ambulatory care providers to collect information on their
characteristics and the characteristics of their practice. The Provider
Electronic Component gathers information on a sample of electronic data
providers including characteristics of the provider, as well as a full
year of electronic patient visit data. Lastly, the HC Component samples
HCs and collects characteristics of the center as well as a full year
of electronic patient visit data.
This revision seeks approval to continue previously approved survey
activities for the completion of the 2022 HC Component's data and to
conduct the full 2023, 2024, and 2025 data years. CDC plans to
implement changes to all three components of NAMCS. HC Component and
Provider Interview Component sample sizes will be adjusted. In 2022,
the goal is to target 100 HCs overall, while the Provider Interview
Component is paused for redesign. In 2023, the goal for NAMCS is to
sample 5,000 physicians, 5,000 advanced practice providers, and up to
150 HCs overall. In 2024, we plan to sample up to 10,000 physicians,
20,000 advanced practice providers, and up to 200 HCs overall (if funds
allow). Lastly, in 2025 CDC will sample up to 20,000 physicians, 40,000
advanced practice providers, and up to 250 HCs overall.
For 2023-2025, there will be an additional 3,000 physicians sampled
yearly for the Provider Electronic Component. The Provider Electronic
Component is modifying its Provider Facility Interview questionnaire
and there are plans to implement a set-up fee in the future. Also, for
the Provider Electronic Component we plan to conduct research on
supplementing electronic visit data with electronic data obtained from
third-party sources. Questions on the Health Center Facility Interview
questionnaire will be modified, and a Set-up Fee Questionnaire will be
implemented. In 2023, the Physician Induction Interview will shift to a
redesigned Ambulatory Care Provider Interview. Also beginning in 2023,
a Tracing Questionnaire will be utilized for the Provider Interview
Component, to increase response rates. Visit data collection via
abstraction will be placed on hold to evaluate improved methods for
collection of these data, and the reinterview study will be
discontinued. The provider incentive experiment will also no longer be
taking place, as we will begin to conduct other methodological work to
improve upon the survey.
CDC requests OMB approval for an estimated 37,744 burden hours.
There are no costs to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
HC Staff.............................. HC Facility Interview 73 1 45/60
questionnaire (Survey
year: 2022).
Prepare and transmit EHR 33 4 60/60
for Visit Data
(quarterly) (Survey
year: 2022).
Set-up Fee Questionnaire 33 1 15/60
(Survey year: 2022).
Physician or Staff.................... ACPI (Survey year: 2023- 11,667 1 30/60
2025).
Contact Tracing (Survey 11,667 1 10/60
year: 2023-2025).
Advanced Practice Provider or Staff... ACPI (Survey year: 2023- 21,667 1 30/60
2025). 21,667 1 10/60
Contact Tracing (Survey
year: 2023-2025).
Ambulatory Care Provider or Group or PFI Survey year: 2023- 3,000 1 45/60
Conglomerate Staff. 2025). 3,000 4 60/60
Prepare and transmit
Electronic Visit Data
(quarterly) (Survey
year: 2023-2025).
HC Staff.............................. HC Facility Interview 300 1 45/60
questionnaire (Survey
year: 2023-2025).
Prepare and transmit EHR 200 4 60/60
for Visit Data
(quarterly) (Survey
year: 2023-2025).
Set-up Fee Questionnaire 200 1 15/60
(Survey year: 2023-
2025).
----------------------------------------------------------------------------------------------------------------
[[Page 59429]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-21218 Filed 9-29-22; 8:45 am]
BILLING CODE 4163-18-P
